A highly sensitive and selective nano-engineered sensor for the online monitoring of mercury vapour emissions from harsh industrial processes. The Australian alumina and aluminium industries contribute over $11 billion export income annually. All refineries, except one, operate in rural areas and are the main economic drivers in these regions. In order to maintain the industry's commitment to reduce the environmental impact of its processes and remain economically sustainable, innovative technol ....A highly sensitive and selective nano-engineered sensor for the online monitoring of mercury vapour emissions from harsh industrial processes. The Australian alumina and aluminium industries contribute over $11 billion export income annually. All refineries, except one, operate in rural areas and are the main economic drivers in these regions. In order to maintain the industry's commitment to reduce the environmental impact of its processes and remain economically sustainable, innovative technologies are required to monitor mercury emissions. The aim of this project is to develop robust sensors, for online monitoring of mercury vapours, that operate under challenging industrial environments. This project will also provide excellent training for young researchers in established international industrial research groups, thereby meeting skill shortages in the Australian resource sector.Read moreRead less
Industrial Transformation Training Centres - Grant ID: IC210100056
Funder
Australian Research Council
Funding Amount
$3,975,864.00
Summary
ARC Training Centre for Next-Gen Technologies in Biomedical Analysis . The Centre for Next-Gen Technologies in Biomedical Analysis will deliver workforce trained in the development of transformative technologies that will rapidly expand the Australian pharmaceutical, diagnostic and defence sector. The university-industry partnership will increase Australia’s manufacturing capability by fast tracking screening, by integrating 3D printing, advanced sensing, big data analytics, machine learning an ....ARC Training Centre for Next-Gen Technologies in Biomedical Analysis . The Centre for Next-Gen Technologies in Biomedical Analysis will deliver workforce trained in the development of transformative technologies that will rapidly expand the Australian pharmaceutical, diagnostic and defence sector. The university-industry partnership will increase Australia’s manufacturing capability by fast tracking screening, by integrating 3D printing, advanced sensing, big data analytics, machine learning and artificial intelligence for the delivery of optimal solutions in diagnosis, treatment and wellbeing. The centre will deliver training in Industry 4.0 skills which will boost early-stage scale-up and accelerate the sector’s supply chain, which is pivotal for the Australian industries to maintain a competitive edge. Read moreRead less
New biosensing strategies based on bipolar electrochemiluminescence. Chemical analysis is a vital activity in our society, which is to a large extent confined to scientific laboratories and carried out with complex instrumentation. The breakthrough technology envisioned in this proposal will pave the way for simple, low-cost tests which can be used by non-scientists. The development of small, portable sensors for applications ranging from pollution monitoring to health testing, will enable ordi ....New biosensing strategies based on bipolar electrochemiluminescence. Chemical analysis is a vital activity in our society, which is to a large extent confined to scientific laboratories and carried out with complex instrumentation. The breakthrough technology envisioned in this proposal will pave the way for simple, low-cost tests which can be used by non-scientists. The development of small, portable sensors for applications ranging from pollution monitoring to health testing, will enable ordinary people to gain knowledge about the concentrations of molecular compounds in their environments and in themselves. This will stimulate economic and social benefits related to environmental testing and early disease diagnosis and generate new commercial opportunities for the Australian biotechnology industry.Read moreRead less